News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
494,002 Results
Type
Article (47774)
Company Profile (35)
Press Release (446193)
Section
Business (139746)
Career Advice (1177)
Deals (26389)
Drug Delivery (81)
Drug Development (63816)
Employer Resources (92)
FDA (12849)
Job Trends (11325)
News (247762)
Policy (25594)
Tag
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (6)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (1)
2024 Pharm Country Digital (1)
2024 Pharm Country Standard (1)
2025 Lone Star Bio Digital (1)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 Biotech Bay Standard (1)
2026 Pharm Country Premier (1)
Academia (2724)
Academic (1)
Accelerated approval (4)
Adcomms (14)
Allergies (64)
Alliances (34091)
ALS (65)
Alzheimer's disease (1161)
Antibody-drug conjugate (ADC) (94)
Approvals (12877)
Artificial intelligence (157)
Autoimmune disease (12)
Automation (7)
Bankruptcy (275)
Best Places to Work (9085)
BIOSECURE Act (16)
Biosimilars (79)
Biotechnology (31)
Bladder cancer (52)
Brain cancer (25)
Breast cancer (216)
Cancer (1676)
Cardiovascular disease (133)
Career advice (961)
Career pathing (16)
CAR-T (122)
Cell therapy (315)
Cervical cancer (19)
Clinical research (51840)
Collaboration (586)
Compensation (146)
Complete response letters (24)
COVID-19 (2351)
CRISPR (27)
C-suite (176)
Cystic fibrosis (72)
Data (1720)
Decentralized trials (1)
Denatured (11)
Depression (32)
Diabetes (202)
Diagnostics (5008)
Digital health (9)
Diversity (7)
Diversity, equity & inclusion (29)
Drug discovery (74)
Drug pricing (76)
Drug shortages (16)
Duchenne muscular dystrophy (72)
Earnings (52777)
Editorial (19)
Employer branding (11)
Employer resources (82)
Events (59908)
Executive appointments (565)
FDA (13791)
Featured Employer (13)
Friedreich's ataxia (1)
Frontotemporal dementia (6)
Funding (502)
Gene editing (70)
Generative AI (13)
Gene therapy (200)
GLP-1 (510)
Government (3476)
Grass and pollen (3)
Guidances (43)
Healthcare (14804)
Huntington's disease (14)
IgA nephropathy (20)
Immunology and inflammation (77)
Indications (25)
Infectious disease (2456)
Inflammatory bowel disease (112)
Inflation Reduction Act (8)
Influenza (41)
Intellectual property (78)
Interviews (190)
IPO (13266)
IRA (27)
Job creations (2552)
Job search strategy (840)
Kidney cancer (9)
Labor market (20)
Layoffs (354)
Leadership (7)
Legal (6396)
Liver cancer (54)
Lung cancer (254)
Lymphoma (114)
Machine learning (3)
Management (26)
Manufacturing (222)
MASH (54)
Medical device (10067)
Medtech (10069)
Mergers & acquisitions (13561)
Metabolic disorders (490)
Multiple sclerosis (65)
NASH (15)
Neurodegenerative disease (66)
Neuropsychiatric disorders (17)
Neuroscience (1557)
NextGen: Class of 2025 (5026)
Non-profit (3564)
Northern California (1808)
Now hiring (16)
Obesity (239)
Opinion (87)
Ovarian cancer (70)
Pain (70)
Pancreatic cancer (67)
Parkinson's disease (110)
Partnered (18)
Patents (174)
Patient recruitment (82)
Peanut (40)
People (44897)
Pharmaceutical (13)
Pharmacy benefit managers (17)
Phase I (15531)
Phase II (22874)
Phase III (17752)
Pipeline (940)
Podcasts (19)
Policy (86)
Postmarket research (1936)
Preclinical (6583)
Press Release (42)
Prostate cancer (80)
Psychedelics (25)
Radiopharmaceuticals (202)
Rare diseases (267)
Real estate (4490)
Recruiting (36)
Regulatory (17387)
Reports (27)
Research institute (2008)
Resumes & cover letters (195)
Rett syndrome (4)
RNA editing (2)
RSV (32)
Schizophrenia (55)
Series A (74)
Series B (44)
Service/supplier (6)
Sickle cell disease (40)
Southern California (1607)
Special edition (10)
Spinal muscular atrophy (118)
Sponsored (20)
Startups (2379)
State (2)
Stomach cancer (8)
Supply chain (40)
Tariffs (5)
The Weekly (8)
United States (16004)
Vaccines (578)
Venture capitalists (18)
Webinars (10)
Weight loss (156)
Women's health (23)
Worklife (4)
Date
Today (39)
Last 7 days (499)
Last 30 days (2052)
Last 365 days (25711)
2025 (6312)
2024 (27249)
2023 (31003)
2022 (38274)
2021 (44402)
2020 (43136)
2019 (34875)
2018 (26826)
2017 (24756)
2016 (22830)
2015 (27341)
2014 (19973)
2013 (16831)
2012 (17988)
2011 (18581)
2010 (16830)
Location
Africa (528)
Alabama (43)
Alaska (5)
Arizona (116)
Arkansas (11)
Asia (29796)
Australia (5128)
California (4119)
Canada (1550)
China (368)
Colorado (209)
Connecticut (209)
Delaware (87)
Europe (63267)
Florida (698)
Georgia (162)
Idaho (40)
Illinois (392)
India (15)
Indiana (230)
Iowa (7)
Japan (118)
Kansas (85)
Kentucky (17)
Louisiana (7)
Maine (49)
Maryland (583)
Massachusetts (2772)
Michigan (164)
Minnesota (223)
Mississippi (2)
Missouri (58)
Montana (26)
Nebraska (14)
Nevada (53)
New Hampshire (55)
New Jersey (1317)
New Mexico (16)
New York (1308)
North Carolina (716)
North Dakota (3)
Northern California (1808)
Ohio (135)
Oklahoma (13)
Oregon (19)
Pennsylvania (983)
Puerto Rico (8)
Rhode Island (19)
South America (791)
South Carolina (14)
South Dakota (1)
Southern California (1607)
Tennessee (86)
Texas (685)
Utah (126)
Virginia (112)
Washington D.C. (45)
Washington State (432)
West Virginia (3)
Wisconsin (27)
494,002 Results for "georgia state university".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Bioxytran Signs NDA with the University of Georgia to Evaluate Galectin Antagonists for Bird Flu Treatment in Chickens
March 19, 2025
·
2 min read
Press Releases
Kaiser Permanente names Corwin N. Harper president of Georgia Region
January 17, 2025
·
3 min read
Press Releases
Improving the Math Behind Stroke Rehabilitation First-of-its-Kind Assistive Robot Enhances Traditional Stroke Recovery by Making Daily Exercises Fun and Engaging
Georgia State researchers are readying the technology for large-scale use by applying advanced math to refine the devices’ ability to autonomously classify range of motion
December 6, 2024
·
1 min read
Drug Development
ASPIRE-FTD Phase 1/2 Clinical Trial Opens in the U.S. at The Ohio State University Wexner Medical Center
AviadoBio today announced that its Phase 1/2 ASPIRE-FTD clinical trial is now open and recruiting patients in the United States at The Ohio State University.
July 1, 2024
·
7 min read
Business
Inhalon Biopharma Expands Therapeutic Horizons with Licensing of hMPV Antibodies from the University of Georgia
Inhalon Biopharma today announced a new agreement with the University of Georgia to license a panel of Human Metapneumovirus (hMPV) antibodies.
November 1, 2023
·
2 min read
Business
Zomedica Increases Manufacturing Capacity with Expansion of its Roswell, Georgia Facility; Can Support Production to Five times Current Levels
Zomedica Corp., a veterinary health company offering diagnostic and therapeutic products for equine and companion animals, completed the expansion of its global manufacturing and distribution facilities in Roswell, Georgia.
June 4, 2024
·
6 min read
Press Releases
Ryoncil® is Now Available for Purchase in the United States
March 27, 2025
·
6 min read
Regulatory
Senate Democrats Demand Return of Fired CDC Staff:
Reuters
Democratic senators from Georgia, Oregon, Maryland and New Mexico called the Trump administration’s decision to terminate hundreds of CDC staffers reckless and unfair.
March 20, 2025
·
2 min read
·
Tristan Manalac
Biotech Bay
AN2 Therapeutics Signs License Agreement with the University of Georgia Research Foundation to Develop Novel Boron-Based Therapy for Chagas Disease
AN2 Therapeutics, Inc. today announced that it has received an exclusive license from the University of Georgia Research Foundation to advance the development of a boron-containing small molecule for Chagas disease.
October 18, 2023
·
6 min read
Press Releases
Meitheal Pharmaceuticals Announces Approval and Launch of Liraglutide Injection in the United States
April 3, 2025
·
7 min read
1 of 49,401
Next
